Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail S Kerr

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
International Immunopharmacology|May 2, 2021
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohortBryant R England, Megan Campany, Harlan Sayles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2020
Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid ArthritisAriadne V Ebel, Gabrielle Lutt, Jill A Poole, et al.
Seminars in Arthritis and Rheumatism|September 26, 2022
Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung diseaseAustin M Wheeler, Joshua F Baker, Jill A Poole, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 2, 2022
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Biomarkers in Axial Spondyloarthritis: Observational Studies From the Program to Understand the Longterm Outcomes in Spondyloarthritis RegistryRouhin Sen, Emmeline Kim, Ruth J Napier, et al.
Seminars in Arthritis and Rheumatism|October 4, 2025
Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trialMichael M Ward, Arthur Weinstein, Paloma Alejandro-Silva, et al.
Arthritis Care & Research|June 2, 2025
Agreement of Administrative Pharmacy Dispensing With Self-Reported Use of Oral Prednisone in US Veterans With Rheumatoid ArthritisBeth I Wallace, Bryant R England, Joshua F Baker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2019
Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary FibrosisDaniel J Kass, Mehdi Nouraie, Marilyn K Glassberg, et al.
Rheumatology (Oxford, England)|November 6, 2024
MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung DiseaseJacob Klein, Austin Wheeler, Joshua F Baker, et al.
Rheumatology (Oxford, England)|October 9, 2023
Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritisJill A Poole, Bryant R England, Harlan Sayles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2024
Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis CohortBrent A Luedders, Austin M Wheeler, Dana P Ascherman, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
International Immunopharmacology|May 2, 2021
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohortBryant R England, Megan Campany, Harlan Sayles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2020
Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid ArthritisAriadne V Ebel, Gabrielle Lutt, Jill A Poole, et al.
Seminars in Arthritis and Rheumatism|September 26, 2022
Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung diseaseAustin M Wheeler, Joshua F Baker, Jill A Poole, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 2, 2022
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Biomarkers in Axial Spondyloarthritis: Observational Studies From the Program to Understand the Longterm Outcomes in Spondyloarthritis RegistryRouhin Sen, Emmeline Kim, Ruth J Napier, et al.
Seminars in Arthritis and Rheumatism|October 4, 2025
Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trialMichael M Ward, Arthur Weinstein, Paloma Alejandro-Silva, et al.
Arthritis Care & Research|June 2, 2025
Agreement of Administrative Pharmacy Dispensing With Self-Reported Use of Oral Prednisone in US Veterans With Rheumatoid ArthritisBeth I Wallace, Bryant R England, Joshua F Baker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2019
Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary FibrosisDaniel J Kass, Mehdi Nouraie, Marilyn K Glassberg, et al.
Rheumatology (Oxford, England)|November 6, 2024
MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung DiseaseJacob Klein, Austin Wheeler, Joshua F Baker, et al.
Rheumatology (Oxford, England)|October 9, 2023
Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritisJill A Poole, Bryant R England, Harlan Sayles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2024
Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis CohortBrent A Luedders, Austin M Wheeler, Dana P Ascherman, et al.
Pageof 8